This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Universitá Degli Studi Di Milano-Bicocca, Universitè De Genève, University Claude Bernard - Lyon 1. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 29 
1 out of 72 
1 out of 215 
Years Active: 2016
Title: Sébastien Tardy: Innovator in Cancer Treatment
Introduction
Sébastien Tardy is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.
Latest Patents
One of his key patents is titled "Alpha-carbolines for the treatment of cancer." This invention relates to inhibitors of the oncogenic protein kinase ALK, which are described by a specific formula. The compounds developed by Tardy are particularly useful in the preparation of medicaments aimed at treating cancer.
Career Highlights
Throughout his career, Sébastien Tardy has worked with prestigious institutions, including Università Degli Studi Di Milano-Bicocca and Université De Genève. His work has focused on advancing medical treatments and improving patient outcomes in oncology.
Collaborations
He has collaborated with esteemed colleagues such as Carlo Gambacorti-Passerini and Luca Mologni, contributing to the advancement of cancer research and treatment methodologies.
Conclusion
Sébastien Tardy's innovative work in developing cancer treatment options highlights his commitment to improving healthcare through scientific research. His contributions are paving the way for future advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile